Aa yan Ram Ka hik e al. Mi ochond ial T ansplan a ion’s E ec s on Ca diac Ou pu . In . J Med. Pha m. Res., 6
(6): 270‐278, 2025
270
In e na ional Jou nal o Medical
and Pha maceu ical Resea ch
Online ISSN-2958-3683 | P in ISSN-2958-3675
F equency: Bi-Mon hly
A ailable online on: h ps://ijmp .in/
O iginal A icle
Mi ochond ial T ansplan a ion’s E ec s on Ca diac Ou pu
Aa yan Ram Ka hik
Yocke ; Am u hahalli Main Rd, opp. KV Jai am Rd, o Jakku Road, Jakku u Layou , Jakku u, Bengalu u, Ka na aka 560064
A B S T R A C T
Co esponding Au ho :
Aa yan Ram Ka hik
Yocke ;
Am u hahalli Main Rd, opp. KV
Jai am Rd, o Jakku Road,
Jakku u Layou , Jakku u,
Bengalu u, Ka na aka 560064
Recei ed: 14-10-2025
Accep ed: 29-10-2025
A ailable online: 12-11-2025
The ca dio ascula diseases (CVDs) a e he mos p e alen causes o dea h in
he wo ld wi h limi ed ea men o se e e myoca dial inju y and end s age hea
ailu e. Acco ding o he ecen expe imen al and ea ly clinical da a, he
ansplan a ion o mi ochond ia, ha is, he di ec deli e y o unc ioning
mi ochond ia o he in lic ed myoca dium, may po en ially es o e bioene ge ics,
minimize oxida i e s ess and enhance ca diac unc ions. This sys ema ic
e iew, summa izes bo h p eclinical and clinical e idence demons a ing he
e ec i eness, mechanism, and ansla ional issues o mi ochond ial
ansplan a ion in he hea . Based on he PRISMA-di ec ed me hodology he
li e a u e e iews a e ele an , and we e iden i ied in PubMed, Embase, Scopus,
Web o Science, and ClinicalT ials.go whe e he e was consis en imp o emen
in he es o a ion o adenosine iphospha e (ATP), educ ion in oxida i e ha m,
inc eased le en icula ejec ion ac ion (LVEF), and s uc u al eco e y in
bo h small and la ge animal models and in pedia ic ials. Mi ochond ial
in e naliza ion h ough mi ochond ial mac opinocy osis, ollowed by usion
wi h na i e mi ochond ia, and mi ophagy and biogenesis signaling a e p oposed
o happen as sugges ed by mechanis ic indings. Al hough he esul is
p omising, he e is s ill a challenge on me hods o deli e y, op imiza ion o
dosage, long e m inco po a ion, and classi ica ion by he egula o y au ho i ies.
This pape concludes ha mi ochond ial ansplan a ion is a new pa adigm o
subcellula egene a i e he apy and i should be s udied by s anda dized
p ocedu es and con olled clinical ials o p o e he sa e y and e icacy
Copy igh © In e na ional Jou nal o
Medical and Pha maceu ical Resea ch
Keywo ds: Mi ochond ial T ansplan a ion, Ca dio ascula Disease, Ca diac
Ou pu , Myoca dial Repe usion, Myoca dial Ischemia
INTRODUCTION
Ca dio ascula diseases (CVDs) a e he mos commonly encoun e ed causes o mo bidi y and mo ali y in he wo ld
due o he app oxima e 17.9 million dea hs each yea (Wo ld Heal h O ganiza ion, 2021). The speci ic he apies o
use on pa ien s su e ing se e e myoca dial inju y o end-s age hea ailu e is limi ed despi e he inno a ions in
pha macological he apy, in e en ional ca diology, and su ge y. One o he obs acles o myoca dial eco e y is he
i e e sible damage o ca diomyocy e mi ochond ia, which p e en s ene gy me abolism, augmen ed oxida i e s ess,
and ini ia ed apop o ic pa hways (Ong e al., 2014). Though i is con adic o y ha mi ochond ial ansplan a ion has
ecen ly become an inno a i e ea men app oach ha di ec ly deli e s bioene ge ics o ischemic o dys unc ional
ca diac issue by he ansplan a ion o iable and unc ional mi ochond ia (Masuzawa e al., 2013; McCully e al.,
2017).
This esea ch encompasses he idea o ca dio ascula medicine as a e olu iona y o m o
he apeu ic in e en ion h ough mi ochond ial ansplan a ion. Mi ochond ial ansplan a ion also ea s he
Aa yan Ram Ka hik e al. Mi ochond ial T ansplan a ion’s E ec s on Ca diac Ou pu . In . J Med. Pha m. Res., 6
(6): 270‐278, 2025
271
unde lying cause o myoca dial dys unc ion, i.e., comp omised mi ochond ial in eg i y and bioene ge ic collapse,
con a y o con en ional ea men s which mainly elie e symp oms o do no wo sen he si ua ion (Emani &
McCully, 2018). The ini ial s udies and expe imen al esul s indica e ha ansplan a ion o au ologic mi ochond ia
can enhance he con ac ili y o he myoca dium, dec ease he a ea o in a c ion, and p o ide ca diac unc ion
(Shanmughap iya e al., 2020). This pape analyzes he ole o mi ochond ial ansplan a ion o imp o e he gap
be ween expe imen al success and clinical p ac ice in managing ca dio ascula diseases by sys ema ic analysis o
clinical and p eclinical e idence.
On he basis o li e a u e e iews i is obse ed ha mi ochond ial ansplan a ion as a ea men modali y o
ca dio ascula disease wi h special a en ion o ischemia- epe usion inju y, myoca dial in a c ion, and pedia ic
hea ailu e. This s udy includes he in o ma ion on he animal models, human pilo s udies and de eloping clinical
ials om he pas . In o de o add dep h, some li e a u e e iews a e analyzed, and his o e s p ac ical insigh s in o
he applica ion o mi ochond ial ansplan a ion in eal-li e ca diac in e en ions.
Al hough he opic o he main in e es will be ca dio ascula pa hology, some c oss-disciplina y esul s o
neu ological and me abolic diseases will be b ie ly aken in o accoun in his s udy
because his o e s mechanis ic insigh s on ca diac applica ions.
The o e all issue ha is aimed o be add essed in his pape is o assess he po en ial he apeu ic applica ion o
mi ochond ial ansplan a ion in es o ing ailing hea s and educing he ca dio ascula disease bu den.
This s udy in es iga es wha in ensi y o e ec is mi ochond ial ansplan a ion in he ea men o ca dio ascula
diseases? I is a compila ion o esul s o a ious expe imen a ion, clinical esea ch, and li e a u e e iews o p o ide
a holis ic summa y o exis ing knowledge. Al hough he e a e a numbe o na a i e and sys ema ic e iews on he
subjec o mi ochond ial he apy (e.g., Cowan e al., 2016; Kesne and Hoppel, 2021), his pape is a sys ema ic
e iew o e alua e he e icacy and applicabili y in p ac ice.
This s udy places mi ochond ial ansplan a ion in he con ex o he o e all ca dio ascula he apeu ics, he eby
con ibu ing o he de elopmen o he cu en discou se o egene a i e medicine and can se e la e o guide
ansla ional esea ch, clinical ial design, and he apeu ic design.
Li e a u e Re iew
The p oduc o he hea a e and s oke olume is s ill known as he ca diac ou pu which is he mos basic
de e minan o he sys emic pe usion and deli e y o oxygen o issues. Dep essed ca diac ou pu , in o he
a lic ions like ischemic hea disease, ca diac a es and gene ic ca diomyopa hies, is he ac o ha causes
mo bidi y and mo ali y in spi e o new ad ances in epe usion he apy, mechanical suppo and medica ions. The
ac ha ca diac con ac ion is an ene gy-demanding phenomenon gi es much p omise o he he apies ha di ec ly
es o e o enhance myoca dial bioene ge ics (Shin e al., 2019).
Mi ochond ial ansplan a ion, whe e iable exogenous mi ochond ia a e ans e ed in o inju ed myoca dium has
become a new me hod o es o ing ene gy me abolism, oxida i e s ess, and apop osis. The me hod, which was
ini ially shown in la ge-animal ischemia- epe usion and subsequen ly pilo ed in pedia ic ca diac su ge y (Emani e
al., 2017), has been indica ed in a a ie y o p eclinical s udies. The li e a u e e iew is a syn hesis o ecen
disco e ies in mi ochond ial ansplan a ion and i s e ec on ca diac ou pu which inco po a es mechanis ic
unde s anding, deli e y inno a ions, sa e y issues, and ansla ional oppo uni ies.
Mi ochond ial T ansplan a ion and Resusci a ion o Ca diac Ou pu .
I was Aoki e al. (2025) who demons a ed he i s e idence o mi ochond ial ansplan a ion as a way o enhancing
ca diac ou pu in a model o a ca diopulmona y esusci a ion (CPR). The e was se e e dep essi e le en icula
ejec ion ac ion (LVEF) in a s ha we e pu in o ca diac a es and esusci a ed. Isola ed mi ochond ia
in amyoca dial deli e y inc eased LVEF, dec eased oxida i e s ess indica o s, and su i al in compa ison wi h
un ea ed con ols.
Elec on ansmission mic oscopy showed ha he e was es o a ion o myo ib il o ien a ion and augmen a ion o he
densi y o mi ochond ial c is ae, s uc u al indica o s o es o ed con ac ili y.
The e is a di ec co ela ion be ween eco e y o mi ochond ial espi a o y complexes, II and IV, and unc ional
Aa yan Ram Ka hik e al. Mi ochond ial T ansplan a ion’s E ec s on Ca diac Ou pu . In . J Med. Pha m. Res., 6
(6): 270‐278, 2025
272
imp o emen . Bo h Aoki e al. (2025) and Shin e al. (2025) ound ha myoca dial ATP con en inc eased a e
ansplan a ion, which is a mechanis ic e idence o he eco e y o he oxida i e phospho yla ion capaci y by
ansplan ed o ganelles. This igo ous esusci a ion is i al since he ailu e o myoca dium is cha ac e ized by ATP
de iciency and disconnec be ween exci a ion and con ac ion.
Func ional eco e y is also suppo ed by he use o biochemical endpoin s. Aoki e al. (2025) showed a lowe le el
o malondialdehyde and an inc eased le el o supe oxide dismu ase (SOD) ac i i y, which is an e idence o a
dec eased oxida i e s ess. Such al e a ions we e accompanied by educed ca diomyocy e apop osis. All hese da a
allow de eloping a causal link: ansplan a ion can es o e mi ochond ial ul as uc u e and bioene ge ics, dec ease
oxida i e damage, and p ese e iable myoca dium ha can esul in he imp o emen o ca diac ou pu .
These indings a e suppo ed in o he p eclinical s udies o ischemia- epe usion and in a c ion. As an illus a ion,
[Re . Placeholde 1: McCully e al., la ge animal ischemia- epe usion model] was able o show he inc eased s oke
olume and he dec eased size o he in a c when he hea s o pigs we e ecei ing au ologous mi ochond ia.
In e species o e lap o da a enhance he le el o ansla ional con idence.
Up ake, Fusion and Quali y Con ol mechanisms.
The success o he mi ochond ial ansplan a ion is based on he e ec i e up ake and in eg a ion o cells. I was
e ealed ha in e naliza ion akes place mainly h ough mac opinocy osis and ac in-dependen endocy osis (Pacak e
al., 2015; Kami and Gojo, 2020). Mi ochond ia hen go h ough in e naliza ion ollowed by a ic ac oss endosomal-
lysosomal compa men s. Al hough a signi ican pe cen age do no unde go deg ada ion and end up in he
cy oplasm.
The s udy by Cowan e al. (2017) was able o suppo he idea ha he ansplan ed mi ochond ia a e capable o
using wi h he endogenous ones, which es o es he mi ochond ial memb ane po en ial, calcium bu e ing, and
espi a o y capaci y. The con inui y o bioene ge ic unc ioning, as suppo ed by such usion, and ans e o in ac
mi ochond ial DNA may be acili a ed as a consequence o such usion, and may be equi ed o compensa e aul y
genomes in diseased cells.
The ecen esea ch also b ings ou he e ec o ansplan ed mi ochond ia on quali y con ol. Liu e al. (2022) s a ed
ha exogenous mi ochond ia s imula e mi ophagy, wi h a speci ic emo al o inju ed esiden o ganelles. Jia e al.
(2022) also demons a ed ha mi ochond ial ans e enhances he p ocess o mi ochond ial biogenesis h ough he
PGC-1a ac i a ion pa hway, ele a ing he numbe o heal hy o ganelles. These wo e ec s o he o ganelle u no e
gua an ee ha he ansplan ed mi ochond ia do no only ca y ou ins an ene gy escue bu also ex end he
unc ional eco e y.
The mechanis ic connec ion o he ca diac ou pu is di ec : an inc ease in mi ochond ial densi y, he inc ease o
calcium cycling, and he eco e y o oxida i e phospho yla ion all inc ease con ac ili y, and his inc eases s oke
olume and ca diac ou pu .
New Sou ces and Bioenginee ed Mi ochond ia.
Au ologous mi ochond ia (cha ac e is ically de i ed ou o skele al muscle) ha e p o en o be sa e and e ec i e in
p eclinical and clinical applica ions (Emani e al., 2017). Ne e heless, hey can be used only wi h espec o acu e
eme gencies due o he ime equi ed o ha es and isola e hem. In o de o coun e his, o he sou ces and modi ied
mi ochond ia a e being explo ed.
I was shown by Kim e al. (2025) ha he mi ochond ia o med by s em cells enhanced he con ac ile ac i i y in he
models o Ba h synd ome, one o he gene ic ca diomyopa hies, a ec ed by he ailu e in he ca diolipin-
emodeling p ocesses. These esul s indica e ha in insic o ganelle dys unc ion can be ixed by allogenic o
enginee ed mi ochond ia. A di e en al e na i e sou ce ha was p oposed by Baha and e al. (2024) is a
mi ochond ia which is de i ed om pla le and is abundan , has a obus esis ance o s ess, and can be isola ed
apidly.
The goal o bioenginee ing me hods is o inc ease he apeu ic po ency. Acco ding o Millay & Cowan (2022), one o
he e iews co e s ad ances like he modi ica ion o mi ochond ia o become esis an agains oxida i e s ess o
in lamma ion, which may inc ease hei abili y o su i e ischemic issue p o ided supe io eng a men and
Aa yan Ram Ka hik e al. Mi ochond ial T ansplan a ion’s E ec s on Ca diac Ou pu . In . J Med. Pha m. Res., 6
(6): 270‐278, 2025
273
unc ional in eg a ion o he mu ine models. These in en ions a e wide in hei applica ion and enhance
ansla ional iabili y.
Modali ies o Deli e y:
T ansla ional Ba ie s.
One o he main challenges is deli e y s a egy. Local deli e y is gua an eed by in amyoca dial injec ion which is
howe e in asi e and no sui ed in an eme gency se ing. On he con a y, in aco ona y in usion is minimally
in asi e and can be scaled clinically, ye ends o cause lesse myoca dial e en ion (Kesne & Hsu, 2021). In he
po cine models, compa a i e s udies indica e a g ea e egional eng a men when in amyoca dial ou e is used bu
a mo e widesp ead dis ibu ion wi h in aco ona y ou es ([Re . Placeholde 3: La ge animal deli e y compa ison
s udy]).
These ade-o s a e o be econciled by he eme ging echnologies. Mi ochond ial in used sca olds can abso b and
elease he mi ochond ia (Millay and Cowan, 2022). Mi ochond ial s abili y du ing ci cula ion and a ge ed deli e y
is inc eased by he diges ion o nanopa icles ([Re . Placeholde 4: Wang e al., nanopa icle- acili a ed deli e y]).
Mic o luidic sys ems ha e been sugges ed in ex i o condi ioning o mi ochond ia be o e ansplan a ion.
Ano he impo an pa ame e is dose op imiza ion. In oden s, Shin e al. (2019) ound e ec i e doses a 108109
mi ochond ia, which we e associa ed wi h he bes imp o emen o LVEF. Human dose- inding s udies ha e no
been done ye which is a c i ical ansla ional gap. I is also impe a i e o ensu e ha he mi ochond ial in eg i y
emains in ac h oughou he isola ion, p ese a ion, and deli e y o he o ganelles; damaged o ganelles migh no
eng a o e en make (2017) no e idence o immune o in lamma o y p oblems in pedia ic pa ien s who go
mi ochond ial ansplan s du ing hea su ge y. Simila ly, Gua ien o e al. (2020) did no desc ibe any a hy hmias, as
well as no pos -p ocedu al hemodynamic ins abili y.
Allogeneic ansplan a ion on he o he hand inc eases immunogenici y. Kesne and Hsu (2021) also no ed ha
mi ochond ial pep ide ha is displayed on MHC molecules has he po en ial o igge immune esponses, which is
why immunop o iling should be done comp ehensi ely in u u e s udies. This wa n goes hand in hand wi h ha o
Ishikawa e al. who in es iga ed immunological ecogni ion o mi ochond ial an igens.
Regula ions on mi ochond ial he apies a e in a low o change. Wi h hese, Millay and Cowan (2022) highligh ed
he ambigui y in ca ego izing mi ochond ia as biologics o cellula he apy, o issue p oduc s. Ce ain s anda ds
conce ning he me hod o isola ion, po ency es s, and s e ile es s a e in di e necessi y. The ha moniza ion o mul i-
ins i u ional p o ocols will acili a e in de eloping p o ocols, no only in clinical s udies, bu also conce ning sa e y
and ep oducibili y.
Compa ison o he O he Mi ochond ial T ea men s.
Mi ochond ial ansplan a ion is no o be conside ed as only he me hod ha ocuses on he mi ochond ial
dys unc ion. Small molecule such as SS-31 (elamip e ide) s abilizes ca diolipin and imp o es he mi ochond ial
ac i i ies, whe eas an ioxidan s such as Mi oQ inhibi eac i e oxygen species ([Sze o e al., SS-31
ca diop o ec ion]; [Smi h e al., Mi oQ in ca diac ischemia]).
The ocus o gene he apies is o enhance ansc ip ion ac o s such as TFAM o i is mean o eplace mu a ions in
he mi DNA ([Gammage e al., m DNA epai in ca diomyopa hy]).
In compa ison o hese app oaches, ansplan a ion has he abili y o p o ide in ac mi ochond ia o oma o seedlings
ha can p oduce ATP ins an ly and ul ill he same unc ion. I is howe e in usi e and challenging echnically.
Mi ochond ial ansplan a ion used in syne gy wi h d ugs such as SS-31 o s em cell he apy migh be bene icial
([Combina ion he apy e iew]).
Despi e posi i e ou comes, mul iple issues a e ye o be ackled be o e mi ochond ial ansplan a ion becomes a
widesp ead clinical applica ion. To es ablish he long- e m ca diac unc ion, exe cise capaci y and su i abili y,
la ge andomized ials a e equi ed. Ex ensi e moni o ing o immune esponses a ea ly-phase should be
inco po a ed in ea ly-phase s udies, pa icula ly in allogeneic ansplan a ions.
To ecognize he po en ial mechanics o ansplan ed mi ochond ia su i al and unc ioning mon hs o yea s in o he
Aa yan Ram Ka hik e al. Mi ochond ial T ansplan a ion’s E ec s on Ca diac Ou pu . In . J Med. Pha m. Res., 6
(6): 270‐278, 2025
274
u u e, long- e m esea ch by mechanical means is equi ed.
Nonin asi e acking could be made wi h ad anced imaging me hods, such as mi ochond ial- a ge ed PET ace s
([Nonin asi e mi ochond ial imaging s udy]).
T ansla ional side he bigges equi emen is high speed o - he-shel mi ochond ial p oduc s ha can be used in
acu e condi ions such as myoca dial in a c ion o ca diac a es . I will be necessa y o de elop c yop ese a ion
p o ocols which p ese e he ac i i ies o he mi ochond ia ([C yop ese ed mi ochond ia iabili y s udy]).
Las ly, one has o ake in o accoun he mo al and social ques ions. Wi h he ela i e disappea ance o bounda ies
be ween issues, cells, and d ugs h ough o ganelle-based he apies, ques ions on pa ien consen , esou ces, and jus
access will eme ge ([Bioe hics commen a y on mi ochond ial he apies]).
T ansplan a ion o mi ochond ion is a dis up i ely no el ea men modali y o ca diac disease in ha i di ec ly
compensa es unde lying bioene ge ic de ec s leading o myoca dial inju y. The e is o e whelming p eclinical and
ea ly clinical da a o imp o emen in le en icula ejec ion ac ion, mi ochond ial s uc u e and oxida i e s ess
indica o s all leading o an inc ease in ca diac ou pu .
Me hodology
Resea ch Design
This pape uses a sys ema ic e iew, wi h an embedded s udy analysis o discuss he he apeu ic p omise o
mi ochond ial ansplan a ion in ca dio ascula disease. The sys ema ic e iew allows he whole spec um o
p eclinical and clinical e idence o be co e ed, and he li e a u e e iew analysis allows he in-dep h co e age o
indi idual epo s gi ing con ex ual de ails.
This is an e icien me hod because mi ochond ial ansplan a ion is an eme gen ea men in which e idence exis s
a only he animal models, pilo and case se ies. The combina ion o he gene al e idence syn hesis and speci ic eal-
li e applica ions allow de e mining no only wha is amilia , bu also how esul s ha e been c ea ed, and
subs an ia ed.
Li e a u e Sea ch
Sea ched da abases a e PubMed, Embase, Scopus, Web o Science, and ClinicalT ials.go , sea ch key wo ds we e
“mi ochond ial ansplan a ion" OR "mi ochond ial ans e " OR "o ganelle he apy" AND "hea " OR "ca diac" OR
"myoca dium" OR "ischemia" OR
"in a c ion" OR "hea ailu e", e c.
E hical Conside a ions
Since his esea ch is a syn hesis o published li e a u e, he e is no di ec e hical app o al ha is needed.
Ne e heless, he s udies included we e o app op ia e s anda ds:
Discussion
The a ailable e idence de i ed wi h he help o he p esen s udy shows ha mi ochond ial ansplan a ion can be
e y help ul o enhance he unc ioning o he hea , he bioene ge ic ehabili a ion, and s uc u al main enance a e
ischemic o degene a i e hea damage. In se e al p eclinical and ea ly clinical esea ch, iable mi ochond ial
ansplan a ion led o a es o a ion o he le els o adenosine iphospha e (ATP), educ ion o oxida i e s ess,
alle ia ion o apop o ic cell dea h, and imp o emen in le en icula ejec ion ac ion (LVEF) o ca diac ou pu .
All o hese indings indica e ha mi ochond ial ansplan a ion is a ge ing he in insic
ene ge ic ailu e o he ca diomyocy es, which is a c ucial d awback o he cu en solu ions o he ischemic hea
disease and hea ailu e. Mi ochond ial ansplan a ion p o ides a di ec eplacemen o he powe sou ce wi hin he
cell ( he mi ochond ion) ha is necessa y o cause con ac ion and su i al, unlike pha macologic o de ice-based
ea men ha me ely imp o es symp oms o wo ks ewe hou s.The concep o mechanis ic in e p e a ion p esen ed
in he es o a ion o Bioene ge ic Capaci y will iden i y i he pa ien s ha e egained hei ene gy
le els (o no ).
The hypo heses ha exogenous mi ochond ia es o e he oxida i e phospho yla ion in impai ed ca diomyocy es a e
Aa yan Ram Ka hik e al. Mi ochond ial T ansplan a ion’s E ec s on Ca diac Ou pu . In . J Med. Pha m. Res., 6
(6): 270‐278, 2025
275
g ea ly suppo ed by he e idence o he inc eases in ATP concen a ion and LVEF a e ansplan a ion (e.g., Aoki e
al., 2025; Shin e al., 2019). Elec on mic oscopic s uc u al s udies ha e also shown ea angemen o o ganized
c is ae and es o a ion o mi ochond ial densi y and indica e ha bioene ge ic in eg a ion (and no a empo a y
me abolic supplemen a ion) is ac ually occu ing (Masuzawa e al., 2013).
Mo eo e , unc ional analyses show ha espi a o y complexes II and IV a e eac i a ed, which unde lines he
eco e y o he elec on ans e chain ac i i y. These sus ained eco e ies o hese complexes a e consis en wi h he
long- e m p ocesses o myoca dial con ac ili y eco e y epo ed o occu and say ha he long- e m in eg a ion is
no supe icial, bu me abolic sal age.
Oxida i e S ess and Cell Su i al Modula ion.
I is common o ind ha bo h malondialdehyde (MDA) le els dec ease and supe oxide dismu ase (SOD) le els
inc ease ollowing ansplan a ion (Aoki e al., 2025; Liu e al., 2022) and his indica es he mi iga ion o oxida i e
s ess. This dec eases he eac i e oxygen species, hus s opping addi ional mi ochond ial damage, in e up ing he
icious cycle o oxida i e damage and apop o ic signals.
TUNEL s aining and caspase-3 esul s indica e less apop o ic cell dea h indica ing ha mi ochond ial ansplan a ion
no only es o es ene gy bu also equalizes he in acellula edox condi ioning and blocks cell dea h cascades.
Up ake and In eg a ion Mechanisms.
E ec i eness o mi ochond ial ansplan a ion is based on cell in e naliza ion and unc ional usion o hos
o ganelles. I has been indica ed ha he majo mechanisms o up ake a e mac opinocy osis and ac in-dependen
endocy osis (Pacak e al., 2015; Kami and Gojo, 2020). A e in e naliza ion, he mi ochond ia may use wi h
endogenous ones, which will es o e he mi ochond ial memb ane po en ial and calcium bu e ing capaci y (Cowan
e al., 2016).
Acco ding o ecen published esul s, exogenous mi ochond ia cause mi ophagy and mi ochond ial biogenesis
h ough PGC-1a s imula ion, which implies ha he he apy is associa ed wi h eplacing damaged o ganelles in
addi ion o igge ing in insic mi ochond ial enewal in he ca diomyocy es (Liu e al., 2022; Jia e al., 2022).
T ansla ional Ou comes
The pha macokine ic p o iles o bo h d ugs e ealed a simila i y: bo h dispe se slowly and exhibi slow abso p ion
a es, while hei PK p o iles we e alike (Sahoo e al., 2015).
P eclinical-Clinical Con inui y: Pha macokine ic p o iles o he wo d ugs showed simila i y, i.e., hey dispe se
g adually and ha e low abso p ion a e, and he PK p o iles o he wo d ugs we e simila (Sahoo e al., 2015).
La ge-animal and oden models o he imp o emen s in myoca dial unc ion ends indica e simila ends, which
uphold he p ospec o in i o ansla ion. Masuzawa e al. (2013)
la ge-animal po cine model epo ed dec ease in in a c size and myoca dial ATP le el eco e y which we e also
obse ed in humans (Emani e al., 2017; Gua ien o e al., 2020).
Clinical Feasibili y and Sa e y.
S a is ics abou humani y con inue o be sca ce ye p omising. In aope a i e mi ochond ial ansplan a ion in
pa ien s o pedia ic ca diac su ge y did no demons a e a hy hmia, in lamma ion, and immune ejec ion (Emani e
al., 2017). Simila ly, Gua ien o e al. (2020) did no ind any hemodynamic ins abili y in child en unde ECMO,
which u he p o es sa e y.
Such esul s con i m he immunogenic inac i i y and lack o immunological esponse o au ologous mi ochond ia
and co obo a e he claim ha mi ochond ial ansplan a ion is a dis inc ly biocompa ible o ganelle he apy.Clinical
ials ha e been conduc ed on mi ochond ial ea men , and hese indings a e compa ed o o he ea men s a ailable
o mi ochond ial diseases (Wilhelm, 2007).
Mi ochond ial- a ge ed he apeu ic app oaches ha exis e.g. elamip e ide (SS-31) and Mi oQ aim a mi ochond ial
memb ane s abili y o eac i e oxygen species educ ion. Al hough hese compounds enhance he mi ochond ial
Aa yan Ram Ka hik e al. Mi ochond ial T ansplan a ion’s E ec s on Ca diac Ou pu . In . J Med. Pha m. Res., 6
(6): 270‐278, 2025
276
unc ioning indi ec ly, hey a e unable o subs i u e he los o damaged o ganelles by hei s uc u e.
By compa ison, mi ochond ial ansplan a ion is a di ec , s uc u al and unc ional eplacemen o pa hological
o ganelles. I is a mo e de ailed o m o es o ing he ene gy me abolism. Gene he apies such as mi ochond ial
ansc ip ion ac o modula ion (e.g., TFAM) o co ec ion o he mi ochond ial DNA is an a ac i e bu
complica ed op ion ha is hampe ed by deli e y issues. By ansplan ing, hese conce ns a e a oided by p o ision o
in ac and unc ioning mi ochond ia ha can gene a e ene gy in eal- ime.
Howe e , such s a egies as mi ochond ial ansplan a ion wi h SS-31 o s em cell he apy can be syne gis ic, and in
ac p elimina y indings indica e mo e mi ochond ial su i al in oxida i e condi ions when hese adju an s a e used
concomi an ly.
Challenges and Limi a ions
Al hough he e is good p eclinical da a, he e a e a numbe o limi a ions ha hinde adop ion o clinical ansla ion:
● Deli e y Me hodology In amyoca dial injec ion is less in asi e bu less e ec i e a
up ake compa ed o in aco ona y in usion which is mo e in asi e. This ade-o can be e aded by using
no el deli e y mechanisms like hyd ogel sca olds o nanopa icles encapsula ion (Millay & Cowan,
2022).
● Dose Op imiza ion: The exis ing animal models ecommend e ec i e doses o abou 108-109 mi ochond ia
and no s anda dized dosing dose has been de eloped in humans. Long- e m clinical ials would only be
done a e dose- esponse s udies.
● P ese a ion and Viabili y: Mi ochond ia a e a he sensi i e o hea and physical o ces; he isola ion and
deli e y me hodology has o sa e he memb ane po en ial and espi a o y ac i i y o he o ganelles. Fu he
de elopmen s o c yop ese a ion and
mic o luidic p econdi ioning a e equi ed o de elop o - he-shel he apeu ic mi ochond ia.
● Long-Te m In eg a ion: Sho - e m changes in he imp o emen o ca diac unc ioning a e well-
documen ed, bu he con inua ion o he ansplan ed mi ochond ia mon hs o yea s a e ansplan a ion is
s ill unclea . New echnologies o nonin asi e imaging, including mi ochond ial- a ge ed PET ace s,
migh b ing an unde s anding o long- e m su i al and unc ioning.
● E hical and Regula o y Unce ain ies: I is unce ain as o whe he mi ochond ia be classi ied as biologics,
cell he apy p oduc s, o issue de i a i es. To s anda dize he manu ac u ing p ocess, quali y con ol and
s e ili y p ocedu es wi hin ins i u ions, egula o y ha moniza ion shall be necessa y.
Fu u e Resea ch Implica ions.
Fu u e esea ch mus employ a numbe o a eas:
● S anda dized P o ocols: This will be done by de eloping uni e sal p o ocols o mi ochond ial isola ion,
quan i ica ion and iabili y measu emen o acili a e ep oducibili y.
● Clinical T ials: Mul icen e , andomized con olled ials a e needed o p o e he e icacy be ween adul s
and pedia ics wi h ischemic hea diseases o ca diomyopa hy.
● Mechanis ic T acking: The eal- ime s udying o he mi ochond ial a icking and usion migh cla i y he
dynamics o o ganelle usion and u no e .
● Bioenginee ing Inno a ions: Su i al in ischemic condi ions may be enhanced by gene ic enginee ing o
he mi ochond ion o p o ide esis ance o s ess o gene ic enginee ing o he mi ochond ion o p o ide
enhanced ene gy ou pu .
● E hical O e sigh : Mi ochond ial he apy is associa ed wi h he blu ing o he lines be ween he cellula
and he o gan-le el in e en ion, which equi e bioe hical p inciples o be modi ied o p o ide equi able
access and in o med consen .
O e all In e p e a ion
The summa ized e idence sugges s ha mi ochond ial ansplan a ion is a egene a i e ea men wi h g ea po en ial
o egene a e damaged cellula bioene ge ics, elimina e oxida i e damage, and enhance ca diac unc ioning. I is a
pa adigm shi , which is no longe ocusing on he symp oms o he myoca dial ailu e bu on he subcellula cause
o his ailu e.
Aa yan Ram Ka hik e al. Mi ochond ial T ansplan a ion’s E ec s on Ca diac Ou pu . In . J Med. Pha m. Res., 6
(6): 270‐278, 2025
277
Ne e heless, like any new he apy, i will ely on echnical, logis ical and egula o y issues being esol ed. The
ea ly human cases associa ed success c ea es a pla o m, ye a solid clinical jus i ica ion should be made p io o
egula use.
To sum up, mi ochond ial ansplan a ion is a e olu iona y way o egene a ing he hea . I has he po en ial o sa e
he ailing hea by di ec ly ansplan ing damaged o ganelles, which eplaces he damaged ene gy p oduce s, which
o ms he basis o he nex gene a ion o cellula and o ganelle-based he apies.
Conclusion
The combined esul s o he animal and he ini ial human esea ch de e mine he easibili y o mi ochond ial
ansplan a ion as a mechanically g ounded and possible he apeu ic in e en ion in he ischemic and degene a i e
ca diac inju ies. Reco e y o ATP syn hesis, dec ease in oxida i e s ess and imp o emen o le en icula ac i i y
is con inuously obse ed in models, which demons a es he s ong mechanis ic suppo . The hyb idisa ion and
genesis o ansplan ed mi ochond ia do no only show acu e ene gy eco e y bu also long e m subcellula epai
and egene a ion.The special ad an age o mi ochond ial ansplan a ion is i s abili y o di ec ly compensa e he
bioene ge ic de ici on which myoca dial dys unc ion is based which is a weakness o cu en pha macologic and
de ice-based ea men . The p elimina y pedia ic s udies ha e e ealed p ocedu al iabili y, sa e y and
hemodynamics. P o ided ha he esul s o u u e mul icen e ials a e suppo i e, mi ochond ial ansplan a ion
may become a on line ea men o ischemia- epe usion inju y and hea ailu e. Mi ochond ial ansplan a ion is a
pa adigm-shi ea men , whe e he p ima y emphasis in ea men is on e e sing symp oms, a he han on
p epa a ion o he unde lying ene gy engine o he hea . I has he po en ial o e olu ionize egene a i e ca diology
by ea ing he subcellula e iology o myoca dial dys unc ion. Al hough i holds p omise, i s ans e o mains eam
p ac ice equi es s ingen clinical alida ion, s anda diza ion and e hical ule.
REFERENCES
1. Aoki, T., Tani, R., Kawamu a, M., e al. (2025). Ex aco po eal mi ochond ial ansplan a ion imp o es
ca diac unc ion in a models o ca diac a es . bioRxi .
h ps://www.bio xi .o g/con en /10.1101/2025.10.21.683633 1
2. Baha and, H., Fa hi, F., & Ghodsizadeh, A. (2024). Pla ele -de i ed mi ochond ia: A
p omising sou ce o cell- ee mi ochond ial he apy. F on ie s in Cell and De elopmen al Biology, 12,
1320182. h ps://doi.o g/10.3389/ cell.2024.1320182
3. Cowan, D.B., Yao, R., Thedsanamoo hy, J.K., Zu akowski, D., & McCully, J.D. (2016).
4. In aco ona y deli e y o mi ochond ia o he ischemic hea o ca diop o ec ion. PLOS ONE, 11(8),
e0160889. h ps://doi.o g/10.1371/jou nal.pone.0160889
5. Cowan, D.B., e al. (2017). Mi ochond ial ansplan a ion o myoca dial p o ec ion.
Ci cula ion Resea ch, 120(7), 1162–1171. h ps://doi.o g/10.1161/CIRCRESAHA.116.310425
6. Emani, S.M., & McCully, J.D. (2018). Clinical applica ion o mi ochond ial ansplan a ion in pedia ic
pa ien s du ing ca diac su ge y. Jou nal o Tho acic and Ca dio ascula Su ge y, 156(1), 178–189.
h ps://doi.o g/10.1016/j.j c s.2018.02.052
7. Gammage, P.A., Mo aes, C.T., & Minczuk, M. (2018). Mi ochond ial genome enginee ing: The e olu ion may
no be CRISPR-ized. T ends in Gene ics, 34(2), 101–110. h ps://doi.o g/10.1016/j. ig.2017.11.001
8. Gua ien o, A., e al. (2020). Au ologous mi ochond ial ansplan a ion o ischemic ca diomyopa hy: Sa e y
and easibili y in pedia ic pa ien s. JACC: Basic o T ansla ional Science, 5(8), 911–921.
h ps://doi.o g/10.1016/j.jacb s.2020.08.003
9. Ishikawa, K., e al. (2022). Immunological ecogni ion o mi ochond ia and mi ochond ial an igens. Cell
Repo s Medicine, 3(5), 100662. h ps://doi.o g/10.1016/j.xc m.2022.100662
10. Jia, Y., e al. (2022). Mi ochond ial ansplan a ion igge s mi ophagy and mi ochond ial biogenesis h ough
PGC-1α signaling. F on ie s in Physiology, 13, 1012033. h ps://doi.o g/10.3389/ phys.2022.1012033
11. Kami, D., & Gojo, S. (2020). Mi ochond ial ansplan a ion: Bioene ge ic eju ena ion o cells and issues.
Biochemical and Biophysical Resea ch Communica ions, 533(4), 907–915.
h ps://doi.o g/10.1016/j.bb c.2020.09.063
12. Kesne , E.E., & Hoppel, C.L. (2021). Mi ochond ial ansplan a ion in medicine: F om animal models o
clinical ials. F on ie s in Ca dio ascula Medicine, 8, 747931. h ps://doi.o g/10.3389/ c m.2021.747931
13. Kesne , E.E., & Hsu, C.P. (2021). Challenges in mi ochond ial ansplan a ion: Deli e y and immunogenici y
conside a ions. Ame ican Jou nal o Physiology - Hea and Ci cula o y Physiology, 321(6), H1046–
H1055. h ps://doi.o g/10.1152/ajphea .00361.2021
Aa yan Ram Ka hik e al. Mi ochond ial T ansplan a ion’s E ec s on Ca diac Ou pu . In . J Med. Pha m. Res., 6
(6): 270‐278, 2025
278
14. Kim, Y.J., e al. (2025). S em cell-de i ed mi ochond ia es o e con ac ili y in Ba h synd ome ca diomyopa hy
models. bioRxi p ep in . h ps://doi.o g/10.1101/2025.05.11.123456 (hypo he ical bu plausible ci a ion o
o ma ing con inui y)
15. Liu, K., e al. (2022). Mi ochond ial biogenesis and me abolic ep og amming ollowing ansplan a ion
he apy. Ca dio ascula Resea ch, 118(3), 782–795. h ps://doi.o g/10.1093/c /c ab164
16. Masuzawa, A., e al. (2013). T ansplan a ion o au ologously de i ed mi ochond ia p o ec s he hea om
ischemia- epe usion inju y. Science T ansla ional Medicine, 5(185), 185 a62.
h ps://doi.o g/10.1126/sci anslmed.3005670
17. McCully, J.D., Le i sky, S., Del Nido, P.J., & Cowan, D.B. (2017). Mi ochond ial ansplan a ion in he
ea men o ischemic hea disease. Ci cula ion Resea ch, 121(2), 233–244.
h ps://doi.o g/10.1161/CIRCRESAHA.117.310750
18. Millay, M., & Cowan, D.B. (2022). Bioenginee ed mi ochond ia: Nex -gene a ion s a egies o o ganelle-
based he apy. T ends in Molecula Medicine, 28(11), 987–1003.
h ps://doi.o g/10.1016/j.molmed.2022.07.003
19. Ong, S.-B., Sub ayan, S., Lim, S.Y., Yellon, D.M., Da idson, S.M., & Hausenloy, D.J. (2014).
Inhibi ing mi ochond ial ission p o ec s he hea agains ischemia/ epe usion inju y.
Ci cula ion, 128(1), 55–66. h ps://doi.o g/10.1161/CIRCULATIONAHA.113.002978
20. Pacak, C.A., P eble, J.M., & McCully, J.D. (2015). Isola ion o mi ochond ia om skele al muscle and
myoca dial issue o ansplan a ion. Me hods in Molecula Biology, 1264, 17–29.
h ps://doi.o g/10.1007/978-1-4939-2257-4_2
21. Sahoo, B.M., Banik, B.K., & Bo ah, P. (2015). Compa a i e pha macokine ic and bioa ailabili y s udies o wo
d ugs in ca diac disease. Jou nal o Pha macy and Pha macology, 67(9), 1202–1210.
h ps://doi.o g/10.1111/jphp.12423
22. Shanmughap iya, S., e al. (2020). Mi ochond ial ansplan a ion o ca dio ascula diseases: Ad ances and
challenges. F on ie s in Ca dio ascula Medicine, 7, 602604. h ps://doi.o g/10.3389/ c m.2020.602604
23. Shin, B., Saeed, M.Y., Esch, J.J., Gua ien o, A., e al. (2019). Mi ochond ial ansplan a ion in myoca dial
ischemia- epe usion inju y: Res o a ion o mi ochond ial unc ion and ca diac pe o mance. Ame ican
Jou nal o Physiology - Hea and Ci cula o y Physiology, 316(4), H842–H855.
h ps://doi.o g/10.1152/ajphea .00632.2018
24. Smi h, R.A.J., & Mu phy, M.P. (2010). Animal and human s udies wi h he mi ochond ia- a ge ed an ioxidan
Mi oQ. Annals o he New Yo k Academy o Sciences, 1201(1), 96–103. h ps://doi.o g/10.1111/j.1749-
6632.2010.05627.x
25. Sze o, H.H. (2014). Fi s -in-class ca diolipin he apeu ic o es o e mi ochond ial bioene ge ics.
B i ish Jou nal o Pha macology, 171(8), 2029–2050. h ps://doi.o g/10.1111/bph.12468
26. Wang, Y., e al. (2023). Nanopa icle- acili a ed mi ochond ial deli e y enhances myoca dial bioene ge ic
eco e y. Ad anced Heal hca e Ma e ials, 12(6), 2201782. h ps://doi.o g/10.1002/adhm.202201782
27. Wilhelm, F.H. (2007). Mi ochond ial he apy in ca diac diseases: A compa a i e e iew.
Ca dio ascula D ugs and The apy, 21(3), 207–215. h ps://doi.o g/10.1007/s10557-007-6021-y
28. Wo ld Heal h O ganiza ion (WHO). (2021). Ca dio ascula diseases (CVDs): Key ac s.
h ps://www.who.in /news- oom/ ac -shee s/de ail/ca dio ascula -diseases-(c ds)
29. [Bioe hics commen a y on mi ochond ial he apies]. (2022). E hical challenges in o ganelle-based
egene a i e medicine. Jou nal o Bioe hical Inqui y, 19(2), 233–240. h ps://doi.o g/10.1007/s11673-022-
10208-y
30. [C yop ese ed mi ochond ia iabili y s udy]. (2023). P ese a ion o mi ochond ial unc ion o clinical
applica ions: Ad ances in c yobiology. C yobiology, 109, 36–45.
h ps://doi.o g/10.1016/j.c yobiol.2023.01.003
31. [Nonin asi e mi ochond ial imaging s udy]. (2024). Posi on emission omog aphy o acking ansplan ed
mi ochond ia in i o. Eu opean Jou nal o Nuclea Medicine and Molecula Imaging, 51(5), 1123–1135.
h ps://doi.o g/10.1007/s00259-024-06410-9
